BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11408485)

  • 1. Differential molecular assemblies underlie the dual function of Axin in modulating the WNT and JNK pathways.
    Zhang Y; Qiu WJ; Liu DX; Neo SY; He X; Lin SC
    J Biol Chem; 2001 Aug; 276(34):32152-9. PubMed ID: 11408485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling.
    Zhang Y; Neo SY; Wang X; Han J; Lin SC
    J Biol Chem; 1999 Dec; 274(49):35247-54. PubMed ID: 10575011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways.
    Kusano S; Raab-Traub N
    Mol Cell Biol; 2002 Sep; 22(18):6393-405. PubMed ID: 12192039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways.
    Zhang Y; Qiu WJ; Chan SC; Han J; He X; Lin SC
    J Biol Chem; 2002 May; 277(20):17706-12. PubMed ID: 11884395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation.
    Luo W; Ng WW; Jin LH; Ye Z; Han J; Lin SC
    J Biol Chem; 2003 Sep; 278(39):37451-8. PubMed ID: 12878610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
    Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
    Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Wnt signaling by Axin and Axil.
    Kikuchi A
    Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling.
    Rui HL; Fan E; Zhou HM; Xu Z; Zhang Y; Lin SC
    J Biol Chem; 2002 Nov; 277(45):42981-6. PubMed ID: 12223491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Axin in the Wnt signalling pathway.
    Kikuchi A
    Cell Signal; 1999 Nov; 11(11):777-88. PubMed ID: 10617280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1.
    Li L; Yuan H; Weaver CD; Mao J; Farr GH; Sussman DJ; Jonkers J; Kimelman D; Wu D
    EMBO J; 1999 Aug; 18(15):4233-40. PubMed ID: 10428961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.
    Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D
    J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Wnt signaling pathway by a novel axin-binding protein.
    Kadoya T; Kishida S; Fukui A; Hinoi T; Michiue T; Asashima M; Kikuchi A
    J Biol Chem; 2000 Nov; 275(47):37030-7. PubMed ID: 10944533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
    Willert K; Shibamoto S; Nusse R
    Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DIX domain protein coiled-coil-DIX1 inhibits c-Jun N-terminal kinase activation by Axin and dishevelled through distinct mechanisms.
    Wong CK; Luo W; Deng Y; Zou H; Ye Z; Lin SC
    J Biol Chem; 2004 Sep; 279(38):39366-73. PubMed ID: 15262978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
    Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
    J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axin-induced apoptosis depends on the extent of its JNK activation and its ability to down-regulate beta-catenin levels.
    Neo SY; Zhang Y; Yaw LP; Li P; Lin SC
    Biochem Biophys Res Commun; 2000 May; 272(1):144-50. PubMed ID: 10872818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
    Hinoi T; Yamamoto H; Kishida M; Takada S; Kishida S; Kikuchi A
    J Biol Chem; 2000 Nov; 275(44):34399-406. PubMed ID: 10906131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.